Elicio Therapeutics (ELTX) Gains from Investment Securities (2020 - 2026)
Elicio Therapeutics (ELTX) reported Gains from Investment Securities of $225000.0 for Q1 2026, down 87.58% quarter-over-quarter from $1.8 million in Q3 2025.
Elicio Therapeutics (ELTX) Gains from Investment Securities (2020 - 2026) Analysis & Trends
Elicio Therapeutics has reported Gains from Investment Securities for 7 years, with the latest figure at $225000.0 in Q1 2026.
- For the quarter ending Q1 2026, Gains from Investment Securities changed N/A year-over-year to $225000.0; the trailing twelve-month figure through Mar 2026 stood at $2.9 million (up 44.68% YoY), and the FY2025 full-year result was $170000.0, up 5566.67% from the prior year.
- Gains from Investment Securities for Q1 2026 stood at $225000.0, down from $1.8 million in the prior quarter.
- The five-year high for Gains from Investment Securities was $5.6 million in Q3 2024, with the low at -$3.6 million in Q2 2024.
- Historically, Gains from Investment Securities has averaged $613700.0 across 5 years, with a median of $124000.0 in 2023.
- The largest YoY upside for Gains from Investment Securities was 93716.67% in 2024 against a maximum downside of 15821.74% in 2024.
- Elicio Therapeutics' Gains from Investment Securities stood at -$39000.0 in 2022, then surged by 61.54% to -$15000.0 in 2023, then jumped by 37546.67% to $5.6 million in 2024, then tumbled by 67.76% to $1.8 million in 2025, then tumbled by 87.58% to $225000.0 in 2026.
- The last three Gains from Investment Securities figures came in at $225000.0 (Q1 2026), $1.8 million (Q3 2025), and $859000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Elicio Therapeutics | 270.44 Mn | 255.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 225,000.00 |
| Mar 31, 2026 | 225,000.00 |
| Sep 30, 2025 | 1.81 Mn |
| Sep 30, 2025 | 1.81 Mn |
| Jun 30, 2025 | 859,000.00 |
| Jun 30, 2025 | 859,000.00 |
| Sep 30, 2024 | 5.62 Mn |
| Sep 30, 2024 | 5.62 Mn |
| Jun 30, 2024 | -3.62 Mn |
| Jun 30, 2024 | -3.62 Mn |
| Mar 31, 2024 | 1.28 Mn |
| Mar 31, 2024 | 1.28 Mn |
| Dec 31, 2023 | -15,000.00 |
| Dec 31, 2023 | -15,000.00 |
| Sep 30, 2023 | -6,000.00 |
| Sep 30, 2023 | -6,000.00 |
| Jun 30, 2023 | 23,000.00 |
| Jun 30, 2023 | 23,000.00 |
| Mar 31, 2022 | -39,000.00 |
| Mar 31, 2022 | -39,000.00 |